Norovirus Infection Disease

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-10-06
Clinical Trial Update: Long-Term Immunogenicity of the Norovirus GI.1/GII.4 Bivalent Virus-like Particle (VLP) Vaccine (NoV Vaccine) in Adults [Phase 2]
Phase 2 trial update assessing long-term immunogenicity of a bivalent norovirus VLP vaccine (NoV Vaccine) in adults; results posted in 2022.